VCAN and breast cancer: Therefore, we speculated that during the BC process, VCAN-AS1 was upregulated, acting as a ceRNA to inhibit the expression and function of miR-106a-5p, a tumor suppressor molecule, thus promoting the progression of BC as a cancer-promoting factor.